Arginine as an eluent for automated on-line Protein A/size exclusion chromatographic analysis of monoclonal antibody aggregates in cell culture.

An automated two-dimensional method using Protein A chromatography followed by size exclusion HPLC was developed for analysis of aggregates of monoclonal antibodies in mammalian cell culture samples. The method development was intended to address the analysis of IgG2 monoclonal antibody products that are particularly prone to aggregation at pH<3.5. An aqueous solution of sodium phosphate at pH 4.3 containing arginine was demonstrated in this work as an excellent eluent for Protein A chromatography. In addition, the arginine solution is a compatible mobile phase for the analysis of these samples by size exclusion HPLC, separating aggregates from the monomer of the monoclonal antibody. The effect of arginine concentration in the eluent on parameters such as protein recovery from Protein A chromatography and resolution of aggregates from the monomer are reported. The developed method was shown to provide accuracy of reported aggregates greater than 98%, and intermediate precision of 4.4% RSD. The method limit of quantitation for aggregates was determined to be 0.1%. Application of the method is demonstrated for analysis of aggregates in cell culture samples to aid in the development of cell culture conditions for the production of antibodies.

[1]  Fred Jacobson,et al.  Protein aggregation and bioprocessing , 2006, The AAPS Journal.

[2]  F. Nicoletti,et al.  The advent of monoclonal antibodies in the treatment of chronic autoimmune diseases , 2010, Neurological Sciences.

[3]  C. J. Hutchings,et al.  Therapeutic antibodies directed at G protein-coupled receptors , 2010, mAbs.

[4]  Kouhei Tsumoto,et al.  Effective elution of antibodies by arginine and arginine derivatives in affinity column chromatography. , 2005, Analytical biochemistry.

[5]  Alois Jungbauer,et al.  Comparison of protein A affinity sorbents. , 2003, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

[6]  D. Mould,et al.  Anti‐TNF Monoclonal Antibodies in Inflammatory Bowel Disease: Pharmacokinetics‐Based Dosing Paradigms , 2012, Clinical pharmacology and therapeutics.

[7]  R D Ricker,et al.  Fast, reproducible size-exclusion chromatography of biological macromolecules. , 1996, Journal of chromatography. A.

[8]  D. Ejima,et al.  Elution of antibodies from a Protein-A column by aqueous arginine solutions. , 2004, Protein expression and purification.

[9]  Hollis Lau,et al.  Acid-induced aggregation of human monoclonal IgG1 and IgG2: molecular mechanism and the effect of solution composition. , 2010, Biochemistry.

[10]  Brian Hubbard,et al.  Downstream processing of monoclonal antibodies--application of platform approaches. , 2007, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

[11]  Jun-fen Ma,et al.  Development of a high throughput protein a well‐plate purification method for monoclonal antibodies , 2009, Biotechnology progress.

[12]  D. Ejima,et al.  Arginine as an effective additive in gel permeation chromatography. , 2005, Journal of chromatography. A.

[13]  D. Ejima,et al.  Mobile phase containing arginine provides more reliable SEC condition for aggregation analysis. , 2010, Journal of pharmaceutical sciences.